Skip to content

Insider · CIK 0001704342

Martin Wilson

officer

Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing Nov 25, 2024, latest Sep 15, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 9
$0 bought, $373k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RCKT: ROCKET PHARMACEUTICALS, INC.

RCKTOct 9, 2026 · close 2.56

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
RCKTsell
ROCKET PHARMACEUTICALS, INC.
$256k
75,364 shares
-11%-
30Weak
RCKTsell 3
ROCKET PHARMACEUTICALS, INC.
$4,593
1,376 shares
-0%+48% from low-68% from high
36Weak
RCKTsell 3
ROCKET PHARMACEUTICALS, INC.
$41k
12,253 shares
-2%+40% from low-70% from high
30Weak
RCKTsell 4
ROCKET PHARMACEUTICALS, INC.
$4,910
1,646 shares
-0%+26% from low-80% from high
30Weak
RCKTsell 3
ROCKET PHARMACEUTICALS, INC.
$4,839
1,592 shares
-1%+30% from low-86% from high
36Weak
RCKTsell 3
ROCKET PHARMACEUTICALS, INC.
$37k
12,109 shares
-8%+30% from low-86% from high
30Weak
RCKTsell 5
ROCKET PHARMACEUTICALS, INC.
$3,784
587 shares
-0%+43% from low-69% from high
30Weak
RCKTsell 5
ROCKET PHARMACEUTICALS, INC.
$6,175
946 shares
-1%+36% from low-70% from high
30Weak
RCKTsell 4
ROCKET PHARMACEUTICALS, INC.
$15k
1,175 shares
-2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-75,364$3.40$256k598,48927 d ago
Feb 18, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,376$3.34$4,593682,000Feb 20, 2026
Feb 13, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-12,253$3.31$41k683,376Feb 18, 2026
Feb 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+311,813$0.00$0695,629Feb 13, 2026
Feb 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+468,187$0.00$0468,187Feb 13, 2026
Nov 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,646$2.98$4,910383,816Nov 20, 2025
Nov 3, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+100,000$0.00$0385,462Nov 10, 2025
Sep 8, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+150,000$0.00$0285,462Sep 9, 2025
Aug 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,004$3.07$3,077136,050Aug 20, 2025
Aug 19, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-588$3.00$1,762135,462Aug 20, 2025
Aug 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-12,109$3.02$37k137,054Aug 18, 2025
May 20, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-587$6.45$3,784149,163May 22, 2025
May 16, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-946$6.53$6,175149,750May 20, 2025
Nov 21, 2024RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,175$13.05$15k63,560Nov 25, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Martin Wilson: insider trades and track record | InsiderTell